Colossal Biosciences

On a quest to revive the woolly mammoth, Colossal Biosciences has created a woolly mouse

Colossal Biosciences, known for its outlandish goal to resurrect the woolly mammoth by 2028, is claiming steady progress. It’s evidence: Genetically engineering mice to have mammoth-like fur. To engineer the woolly mouse, the company’s scientists found mouse versions of mammoth genes and then used CRISPR to edit mice embryos, Dr. Beth Shapiro, chief science officer […]

On a quest to revive the woolly mammoth, Colossal Biosciences has created a woolly mouse Read More »

Colossal Biosciences raises $200M at $10.2B valuation to bring back woolly mammoths

Colossal Biosciences, the company that’s famously on a mission to bring back the woolly mammoth and two other extinct species, has raised a $200 million Series C at a $10.2 billion valuation from TWG Global, the investment company of Guggenheim Partners co-founder Mark Walter, and the billionaire Thomas Tull. The funding comes two years after

Colossal Biosciences raises $200M at $10.2B valuation to bring back woolly mammoths Read More »